RSS

CYDY CytoDyn Inc

Mod: mightycydy Asst: HHIGambler,CaptnAmerca
Last Post: 10/12/26
Followers: 439
Posts Today: 0
Views Today: 2773

CYDY Stock Quote & Tools

$0.2000 ▲ +0.0000 (+0.00%) As of Oct 12, 3:52 PM EDT
Last0.2000
$ Chg0.0000
Open0.1982
High0.2072
Beta1.4964
Year High0.397
Market Cap293.90M
P/B Ratio-2.68
EPS-0.03
Avg Vol (30d)1.60M
Volume1.17M
% Chg+0.00%
Prev Close0.2000
Low0.1970
VWAP0.19940
Year Low0.183
Total Shares1.47B
Shares Out1.47B
Float1.36B
ExchangeOTCQB
Healthcare Biotechnology & Life Sciences
Company Profile Buy Rating Time & Sales News Filings Financials

CYDY Stock Message Board Discussion

3 Pinned Posts
Leronlimab (Pro 140) Cliff Notes What is it? Leronlimab is a humanized monoclo (43) by trding
Leronlimab Regulator List (a work in progress) = upregulation = downregulation a-SMA (21) by ohm20
EIND: Information to Submit to Doctors Leronlimab a humanized monoclonal antibody binds CCR5, (38) by ohm20
  1. LaundryMoney

    If you want some light reading or suffer from insomnia here is what that means

    (1)
  2. SeeWhyDY

    I just received an email for a SEC Filing Alert D: Official notice of an offering of securities

    (2)
  3. invisioner

    I understand where you are coming from and I had the same concern, but doesn't the p value not need

    (1)
  4. fsoalex

    Oops, December 2.

  5. fsoalex

    The official proclamation was effective the day it was published in the official gazette, December

  6. Shelly2626

    I have friends who have been turned away...I don't tell them too much as I just let them know the

    (3)
  7. Shelly2626

    Exactly...that's why I think the timing this time around is a little different...because approval

    (1)
  8. Riztheinvestor

    10 then maybe 30 plus after approval ?!

    (2)
  9. nmbr1stckpckr

    I agree. I think we see a steady rise for the next week pr two, possibly another run to

    (1)
  10. JLang

    That could totally happen as well... Just saying "don't be surprised" if it doesn't. I expect

    (1)
  11. JLang

    No doubt. I'm not surprised that administration is proving difficult, but 5-20% is beyond

    (1)
  12. nmbr1stckpckr

    Good point. With all the expected deaths, completion of a phase 3 trial is news that may generate

  13. JLang

    Well, if you're going to insist on being That Guy, I would totally ignore the DSMC because they

    (10)
  14. Shelly2626

    Agreed..should be more FOMO each day now

  15. Shelly2626

    We'll see....timing is interesting right now

    (1)
  16. Evil Rabbit

    Disagree. Clock is ticking now. More investors will get in. Others will accumulate. It really is

    (6)
  17. Cassandra X

    FDA people are working remotely like many others. You can't get them by phone, you leave a msg and

  18. mtruong34

    MABs by Lilly & Regeneron going unused due to complicated administration for m/m population. Real

    (3)
  19. JLang

    A lot of flippers & day traders have gotten in waiting for this announcement... Don't be surprised

    (2)
  20. sunclouds

    The DMSC determines if a trial should continue based on safety and efficacy but since the trial is

    (4)
  21. ClosetInvestor

    The DSMC is irrelevant because the trial is over. Good idea, ignore recommendations of the

  22. ClosetInvestor

    Bribery is cheap there and there may even be a deferred payment plan. Ah, Samsung style

    (1)
  23. JLang

    The DSMC is irrelevant because the trial is over. Move along to the next bash

    (6)
  24. jeff67

    The pharma partner they have in the Philippines is very savvy in how to get things done there. I

    (2)
  25. ohm20

    CYDY doesnt have a large enough bribe CYDY won't be bribing anyone. Companies

    (1)
  26. enemyofpluto

    Didn't the UK PR come about 1 am EST, or 7am Uk time? We just need to get Nader moved to a

  27. StinkyPennies

    Just watched the Dr. Been show w/ Dr. Patterson. Here were a few Dr. Yo posts during the comments

  28. SizzlChest

    You sir hit the nail on the head. I am a day trader, and there is one stock I sold a good amount

    (4)
  29. enemyofpluto

    Pretty sure it came with the Philippines PR that the changes set to take effect on allowing more

    (1)
  30. Shelly2626

    I do very much agree that for some reason CYDY announces things at 2pm pacific time.....and yes

    (1)
  31. mtruong34

    Either Cytodyn doesn't realize the EO is officially in effect or maybe there is some other red tape

  32. ClosetInvestor

    PR today means Nader could get scheduled on a business channel tomorrow. What are the chances he

  33. ChasingWealth

    PR today means Nader could get scheduled on a business channel tomorrow. What are the chances he

    (1)
  34. Hyperbolic

    Today I was driving by the headquarters of CYDY and I thought of the interview I watched a couple

    (8)
  35. ClosetInvestor

    If they're smart on a CD10 EUA they'll buy everything. The CD10 data isnt robust enough,

    (2)
  36. Respert24

    If I could no longer post my patented brand of ridiculousness and had to choose someone else's

    (6)
  37. enemyofpluto

    Yeah, that's what I saw too, that it appeared to be amended to take effect 12/2 instead of Jan 1

    (1)
  38. ohm20

    A PR gets wider notice than a conference call. As long as there's enough demand shorts can't drive

    (1)
  39. Shopcop7

    Wait too long to get back in did ya? hehehe

    (2)
  40. ohm20

    I wonder how much leronlimab they will buy ahead of FDA EUA If they're smart on

    (5)
  41. craigakess

    Telegraphed what, that CD12 was about to be filled? He didn't telegraph it, he said it outright.

  42. ClosetInvestor

    ...I thought we will do 28 and 42 days check...??? Why not?? Exactly. I hope the canceling of

    (2)
  43. nmbr1stckpckr

    Hopefully, no one will care about results at 42 days.

    (3)
  44. nmbr1stckpckr

    So we may have Philippines EUA before the end of this month. I wonder how much leronlimab they

  45. Shelly2626

    CI......sorry for being confused and neophyte ...I thought we will do 28 and 42 days

  46. invisioner

    It would seem to me that the reason would be that more people die after 42 days than after 28, that

    (2)
  47. Goosebumps

    I am betting with impending revenue in the not so distant future. We see a surge in stock price

    (7)
  48. ohm20

    I am anxious to see how the sock price reacts tomorrow to this PR. The shorts

    (7)
  49. Rubraquercus

    10,000 likes for this post, ugh, sadly

  50. Nevergiveup7

    Maybe even stock price

    (1)

Top 10 Most Recent News Articles

More News Articles

Top 5 Most Recently Viewed Articles

Syntec Optics Strengthens Position with $1.9 Million Order

Updated Category News Views 170

Syntec Optics Secures New $1.9 Million Order for Space Optics Syntec Optics Holdings, Inc. (NASDAQ: OPTX), a notable player in the technology sector, has received an impressive new order valued at approximately $1.9 million. This recent order is for cutting-edge Low Earth Orbit (LEO) satellite optics, marking a significant achievement for the company as it expands its...

Continue Reading
CPI Card Group Inc. Faces Scrutiny Over Financial Discrepancies

Updated Category News Views 205

Investigation into CPI Card Group Inc. Recent developments have raised eyebrows in the investment community regarding CPI Card Group Inc. (NASDAQ: PMTS). As stakeholders seek clarity on the company's operations, investigations have begun into potential discrepancies in financial reporting. Investors holding stakes in CPI are encouraged to seek information as various...

Continue Reading
Belite Bio's Q2 Financial Update: Promising Developments Ahead

Updated Category News Views 291

Belite Bio's Promising Developments in Q2 2025 Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company at the forefront of creating innovative therapies for degenerative retinal diseases, recently shared its financial results for the second quarter of 2025, and it's packed with encouraging milestones. Key Clinical Milestones Achieved During this quarter,...

Continue Reading
Ryde Group Introduces Exciting Cashback Challenge for All

Updated Category News Views 176

Ryde Group Launches a Festive Cashback Challenge Ryde Group Ltd (NYSE American: RYDE), a technology leader known for its innovative mobility platform in Singapore, is ushering in the holiday season with the launch of its Supersized Cashback Christmas Challenge. This exceptional campaign is tailored for Ryde+ subscription members and is designed to enhance rider loyalty...

Continue Reading
How inDrive Transformed Profitability with SHIELD's Intelligence

Updated Category News Views 336

inDrive Achieves Remarkable ROI with Device-First Intelligence A recent study indicates that SHIELD's advanced Device Intelligence technology has enabled inDrive, a global mobility company, to eliminate fraud effectively and boost profitability. This initiative has resulted in an impressive $104.6 million in benefits over three years. Overview of the SHIELD Device...

Continue Reading